---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-346796"
form_type: "8-K"
ticker: "SGMO"
cik: "0001001233"
company_name: "SANGAMO THERAPEUTICS, INC"
filed_at: "2026-08-12T20:02:53+00:00"
generated_at: "2026-08-12T20:04:24.605553+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Sangamo files June monthly operating report; cash $14.38M, net loss $3.76M in Chapter 11

## Summary
- Chapter 11 filed June 23, 2026; case No. 26-10989 in Delaware; stock now OTC under SGMOQ.
- Cash balance $14.38M at June 30, 2026; drew $10.5M under initial DIP facility during June.
- June net loss $3.76M; gross income $108,953, G&A $1.10M, reorganization items $2.01M.
- Prepetition unsecured debt $78.13M; total liabilities $89.15M; total assets $153.09M.
- 73 full-time employees as of June 30; professional fees and DIP financing approved by court.

## SEC filing metadata
- accession: 0001193125-26-346796
- form_type: 8-K
- ticker: SGMO
- cik: 0001001233
- company_name: SANGAMO THERAPEUTICS, INC
- filed_at: 2026-08-12T20:02:53+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1001233/000119312526346796/0001193125-26-346796-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1001233/000119312526346796/d21956d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-346796
- JSON: https://secwatch.observer/filing/0001193125-26-346796.json
- Plain text: https://secwatch.observer/filing/0001193125-26-346796.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.